News

Protopic Ointment (tacrolimus) is indicated to treat moderate to severe eczema. Brand sales were approximately $176 million over the last 52 weeks according to Symphony Health Solutions. Perrigo’s

In addition, two approximately $80 million contingent milestones are payable for the approval of drisapersen in the U.S. no later than May 15, 2016 and Europe no later

The composition of the Diabetes Consortium has evolved over many months. In addition to key personnel from Nuvilex, it consists of principals from Austrianova – Prof. Dr. Walter

To date, CAR-T therapies have shown promise in early human clinical trials for the treatment of blood cancers and allogeneic CAR-Ts have the potential for use as off-the-shelf

rVSV-EBOV was originally developed by the Public Health Agency of Canada (PHAC) and is currently being evaluated in Phase I clinical trials. Merck Vaccines president Dr Julie Gerberding

The new five year agreement, which extends through December 2019, creates efficiencies for both companies by leveraging the strength of Omnicare as the nation’s largest institutional pharmacy and

Psoriasis is an immune mediated skin condition characterised by raised scaly lesions on the skin. It affects approximately 14 million people across Europe and about 125 million people

Opdivo is BMS’s investigational PD-1 (programmed death-1) immune checkpoint inhibitor, while FPA008 is Five Prime’s monoclonal antibody that inhibits colony stimulating factor-1 receptor (CSF1R). As part of the

The company has also notified the owner of the Reference Listed Drug of its filing. In November, Endo Pharmaceuticals Solutions, Bayer Intellectual Property and Bayer Pharma filed suit